Brief: Finch Therapeutics Reports Third Quarter 2021 Financial Results
10/11/2021 12:16
Nov 10 (Reuters) - Finch Therapeutics Group Inc FNCH.O :
* FINCH THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATES
* FINCH THERAPEUTICS GROUP INC - QTRLY TOTAL REVENUE $11.3
MILLION
VERSUS $1.8 MILLION
* FINCH THERAPEUTICS GROUP INC - QTRLY NET LOSS PER SHARE
$0.21
Source text for Eikon: ID:nGNX11SbRX
Further company coverage: FNCH.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Finch Therapeutics
See all newsFinch wins US jury trial against Ferring over fecal-transplant patents
Brief: Finch Therapeutics Group Received A Notice From Nasdaq Acknowledging Fact That Co Does Not Meet Requirements Of Rules On April 2
Brief: Finch Therapeutics Got Letter From Nasdaq That Co Has Regained Compliance With Nasdaq’s Listing Rule 5450(A)(1)
U.S. STOCKS ON THE MOVE-Gold miners, ImmunoGen, Oracle
U.S. STOCKS ON THE MOVE-Teekay, gold miners, Oil-Dri Corp